Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of RCBTB2 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Host species | Goat |
| Applications | ELISA |
More info about RCBTB2 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB15659 |
| Product name: | RCBTB2 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised aganist synthetic peptide of RCBTB2. |
| Gene id: | 1102 |
| Gene name: | RCBTB2 |
| Gene alias: | CHC1L |
| Gene description: | regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 |
| Immunogen: | A synthetic peptide corresponding to amino acids at internal region of human RCBTB2. |
| Immunogen sequence/protein sequence: | CEHFRSSLEDNEDD |
| Protein accession: | NP_001259.1 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:2000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Applications: | ELISA |
| Shipping condition: | Dry Ice |
| Publications: | Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks.Uren AG, Kool J, Matentzoglu K, de Ridder J, Mattison J, van Uitert M, Lagcher W, Sie D, Tanger E, Cox T, Reinders M, Hubbard TJ, Rogers J, Jonkers J, Wessels L, Adams DJ, van Lohuizen M, Berns A. Cell. 2008 May 16;133(4):727-41. |